Mirda Danielle, Dungan Michaela, Ren Yue, Li Hongzhe, Katona Bryson W
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cancers (Basel). 2024 Nov 30;16(23):4021. doi: 10.3390/cancers16234021.
The expected and optimal adenoma detection rate (ADR) is not well characterized in Lynch syndrome (LS). The aim of this study is to determine the ADR, the overall colorectal neoplasia detection rate (CNDR), proximal serrated detection rate (PSDR), and CRC detection rate (CRCDR) in an LS cohort.
A retrospective study was performed of individuals with LS who were evaluated at a single tertiary care center from May 2001 to September 2023 ( = 542). Data from procedure and pathology reports were collected along with relevant demographic, clinical history, and family history data. Fisher's exact test and the Kruskal-Wallis test were used to assess factors associated with colorectal neoplasia.
Amongst 542 individuals with LS, 352 met the inclusion criteria, and their 1296 colonoscopies/sigmoidoscopies were used for analysis. The cohort was primarily female (64.5%), white (87.5%), and privately insured (76.1%), with a near even distribution across genotypes. CNDR was 27.9%, ADR was 21.4%, PSDR was 7.7%, and CRCDR was 1.5%. Advanced age, Medicare insurance, prior colonic resection, and prior history of non-CRC were significantly associated with an increased CNDR and ADR ( < 0.05). PSDR remained constant with age. There was no association with genotype, biological sex, race, smoking, BMI, aspirin use, nor family history.
Despite frequent colonoscopies/sigmoidoscopies, individuals with LS maintain a high rate of colorectal neoplasia, primarily driven by increased detection of adenomas with advancing age. Neoplasia rates may serve as helpful "ballpark rates" for endoscopists performing colonoscopies/sigmoidoscopies in LS. However, further studies need to determine whether neoplasia rates are predictive of CRC risk and outcomes in LS.
林奇综合征(LS)中预期的和最佳的腺瘤检出率(ADR)尚未得到充分描述。本研究的目的是确定LS队列中的ADR、总体结直肠肿瘤检出率(CNDR)、近端锯齿状病变检出率(PSDR)和结直肠癌检出率(CRCDR)。
对2001年5月至2023年9月在单一三级医疗中心接受评估的LS患者进行回顾性研究(n = 542)。收集了手术和病理报告的数据以及相关的人口统计学、临床病史和家族史数据。采用Fisher精确检验和Kruskal-Wallis检验来评估与结直肠肿瘤相关的因素。
在542例LS患者中,352例符合纳入标准,其1296次结肠镜检查/乙状结肠镜检查用于分析。该队列主要为女性(64.5%)、白人(87.5%)且有私人保险(76.1%),各基因型分布接近均匀。CNDR为27.9%,ADR为21.4%,PSDR为7.7%,CRCDR为1.5%。高龄、医疗保险、既往结肠切除术和非结直肠癌既往史与CNDR和ADR升高显著相关(P < 0.05)。PSDR随年龄保持稳定。与基因型、生物学性别、种族、吸烟、BMI、阿司匹林使用及家族史无关。
尽管频繁进行结肠镜检查/乙状结肠镜检查,但LS患者的结直肠肿瘤发生率仍然很高,主要是由于随着年龄增长腺瘤检出率增加。肿瘤发生率可能有助于为对LS患者进行结肠镜检查/乙状结肠镜检查的内镜医师提供有用的“大致发生率参考”。然而,需要进一步研究以确定肿瘤发生率是否可预测LS患者的结直肠癌风险和预后。